These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10668936)

  • 1. Glycosaminoglycans excretion in interstitial cystitis.
    Akçay T; Konukoğlu D
    Int Urol Nephrol; 1999; 31(4):431-5. PubMed ID: 10668936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC; Politano VA; Selzer MG; Lokeshwar VB
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis.
    Soler R; Bruschini H; Truzzi JC; Martins JR; Camara NO; Alves MT; Leite KR; Nader HB; Srougi M; Ortiz V
    Int Braz J Urol; 2008; 34(4):503-11; discussion 511. PubMed ID: 18778502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis.
    Buffington CA; Blaisdell JL; Binns SP; Woodworth BE
    J Urol; 1996 May; 155(5):1801-4. PubMed ID: 8627887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity.
    Lokeshwar VB; Selzer MG; Cerwinka WH; Gomez MF; Kester RR; Bejany DE; Gousse AE
    J Urol; 2005 Jul; 174(1):344-9. PubMed ID: 15947687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR; Ordille S; Martin A; Bhavanandan VP
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.
    Lokeshwar VB; Selzer MG; Unwala DJ; Estrella V; Gomez MF; Golshani R; Kester RR; Klumpp DJ; Gousse AE
    J Urol; 2006 Sep; 176(3):1001-7. PubMed ID: 16890679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
    Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the metabolism of glycosaminoglycans in patients with interstitial cystis.
    Lucon M; Martins JR; Leite KR; Soler R; Nader HB; Srougi M; Bruschini H
    Int Braz J Urol; 2014; 40(1):72-9. PubMed ID: 24642152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis.
    Bouchelouche K; Kristensen B; Nordling J; Horn T; Bouchelouche P
    J Urol; 2001 Dec; 166(6):2121-5. PubMed ID: 11696719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects.
    Maccari F; Buzzega D; Galeotti F; Volpi N
    Int Urogynecol J; 2011 Dec; 22(12):1581-6. PubMed ID: 21809155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ls clinical practice aligned with the latest scientific evidence on GAG therapy?
    Janssen DAW
    Urologia; 2017 Sep; 84(Suppl 1):16-20. PubMed ID: 28862729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased urinary uronic acid levels in individuals with interstitial cystitis.
    Parsons CL; Hurst RE
    J Urol; 1990 Apr; 143(4):690-3. PubMed ID: 2313793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary excretion of leukotriene E(4) in patients with interstitial cystitis.
    Bouchelouche K; Kristensen B; Nordling J; Horn T; Larsen S; Hald T; Bouchelouche P
    Urology; 2001 Jun; 57(6 Suppl 1):128. PubMed ID: 11378123
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated urinary levels and urothelial expression of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein in patients with interstitial cystitis.
    Makino T; Kawashima H; Konishi H; Nakatani T; Kiyama H
    Urology; 2010 Apr; 75(4):933-7. PubMed ID: 19646740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stretch-activated release of adenosine triphosphate by bladder uroepithelia is augmented in interstitial cystitis.
    Sun Y; Keay S; DeDeyne P; Chai T
    Urology; 2001 Jun; 57(6 Suppl 1):131. PubMed ID: 11378132
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of the kallikrein kinin system in interstitial cystitis.
    Rosamilia A; Clements JA; Dwyer PL; Kende M; Campbell DJ
    J Urol; 1999 Jul; 162(1):129-34. PubMed ID: 10379755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis.
    Hurst RE; Parsons CL; Roy JB; Young JL
    J Urol; 1993 Jan; 149(1):31-5. PubMed ID: 8417212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis.
    Tencer J; Torffvit O; Grubb A; Björnsson S; Thysell H; Rippe B
    Nephrol Dial Transplant; 1997 Jun; 12(6):1161-6. PubMed ID: 9198045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycan excretion in urolithiasis.
    Akçay T; Konukoğlu D; Dínçer Y
    Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.